The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.

The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.

Item
http://www.wikidata.org/entity/Q47207711
Molecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literatureSynovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors.Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest ChinaExpression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcomaPrognostic value of SS18-SSX fusion type in synovial sarcoma; systematic review and meta-analysis.The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.SMARCB1-deficient Tumors of Childhood: A Practical Guide.The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.Primary synovial sarcoma of the uterus.
P2860

The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.

Item
http://www.wikidata.org/entity/Q47207711
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
type
label
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
prefLabel
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The classic prognostic factors ...... usion type or ezrin expression
@en
P2093
P304
P31
P356
10.1097/PAI.0B013E31818A6F5C
P433
P478
P50
P577
P698